DexCom (DXCM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the ...

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade ...

Earlier this month, DexCom reported stronger-than-expected second quarter revenues but issued the weakest full-year outlook among patient monitoring peers, following a sector-wide selloff triggered by ...

DexCom's devices are important to its customers' health. The company still has significant whitespace in its market. Despite potential obstacles, the stock is still attractive. Even so, the ...

In a report released on October 3, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom, with a price target of $85.00. The company’s shares closed yesterday at $66.36. El ...

Shares of DexCom Inc. DXCM shed 3.06% to $76.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.30% to 6,532.04 and the ...

We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ ...

Two major diabetes tech companies, Dexcom and Insulet, are making changes to their C-suites. Dexcom disclosed that the current CEO of the continuous glucose monitor maker, Kevin Sayer, will be taking ...

At the 61st annual European Association for the Study of Diabetes Conference (EASD) this week in Vienna, Austria, glucose monitoring company Dexcom introduced its new offering, the Dexcom Smart Basal, ...

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. DexCom’s shares are quite volatile and have had 15 moves greater than 5% over the ...